Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Drugmakers Pipelines News Monitoring

Get by Email • RSS

Published on May 29, 2025

Veeva Systems Inc. (NYSE:VEEV) Q1 2026 Earnings Call Transcript

Veeva Systems Inc. (NYSE:VEEV) Q1 2026 Earnings Call Transcript May 28, 2025 Veeva Systems Inc. beats earnings expectations. Reported EPS is $1.97, expectations were $1.74. Operator: Ladies and gentlemen, thank you for standing by. My name is Abby, and I …

Source: Insider Monkey - Neutral
Published on May 29, 2025

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day

Teva outlines acceleration path into a leading biopharma company Innovative medicines franchise on track to exceed $5 billion by 2030, led by AUSTEDO® (deutetrabenazine), AJOVY® (fremanezumab), UZEDY® (risperidone) and late-stage pipeline with blockbuster …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025

SK Bioscience Expands Vaccine Production Capacity for Global Market Penetration

SK Bioscience is accelerating its efforts to expand its production infrastructure to penetrate the global market. On May 29, the company announced the completion of the expansion of its vaccine production facility, 'L HOUSE,' located in Andong, …

Source: Korea IT Times - Neutral
Published on May 29, 2025

Hyperammonemia Treatment Market to Reach USD 2,450 Million by 2035 Amidst Growing Focus on Rare Disease Therapies | FMI

Hyperammonemia Treatment Market Outlook: Key Trends, Growth Drivers & Emerging Therapeutics from 2025 to 2035 NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global hyperammonemia treatment market is poised for significant …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025

Global Laband Syndrome Therapeutics Market Set for Strong Growth Amid Advancements in Rare Disease Treatments | FMI

Laband Syndrome Therapeutics Market Set to Evolve with Innovation and Emerging Trends from 2025 to 2035 NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global laband syndrome therapeutics market is on a significant growth …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025

Hutchinson-Gilford Progeria Syndrome Market Set for Robust Expansion, Projected to Reach USD 261,956.6 Million by 2035

Emerging therapies and innovations drive Hutchinson-Gilford Progeria Syndrome market growth from 2025 to 2035 across diagnostics and treatment NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global hutchinson-gilford progeria …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025

Anal Cancer Market Heats Up Following Incyte's Zynyz Greenlight Delveinsight

(MENAFN- PR Newswire) Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy and targeted therapies gain traction, …

Source: MENAFN - Indeterminate
Published on May 29, 2025

Thrombocytopenia Treatment Market to Surpass USD 10,611.9 Million by 2035 Rising Demand for Targeted Therapies | FMI

Explore growth drivers, innovations, and future trends shaping the Thrombocytopenia Treatment Market from 2025 to 2035 NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global thrombocytopenia treatment market is poised for …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025

B-Cell Inhibitors Market Poised For Significant Advances During The Forecast Period (2025-2034) Across 7MM Due To Novel ...

(MENAFN- PR Newswire) The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which includes indications like IgAN, Multiple Sclerosis, Immune Thrombocytopenia, SLE, IgG4-RD, wAIHA, …

Source: MENAFN - Indeterminate
Published on May 28, 2025

New Eli Lilly acquisition to progress potential next-generation pain treatment

The deal will support Eli Lilly and Company to advance non-opioid medicines and expand its pain therapy pipeline. Eli Lilly and Company has agreed to acquire the biotech SiteOne Therapeutics, Inc. Shareholders of SiteOne will be eligible for a total of $1. …

Source: European Pharmaceutical Review - Neutral
Published on May 28, 2025

Eli Lilly to buy SiteOne for $1 billion

Pharmaceutical company Eli Lilly has announced plans to acquire private biotech company SiteOne in a deal worth up to $1 billion. This move has been done to expand the company’s neuroscience pipeline with a focus on non-opioid pain treatments. This …

Source: The American Bazaar - Center-left
Published on May 29, 2025

Global Smart Inhalers Market To Observe Impressive Growth At A CAGR Of ~21% By 2032 Delveinsight

(MENAFN- GlobeNewsWire - Nasdaq) The smart inhalers market is experiencing significant growth, driven by the increasing incidence of respiratory diseases like asthma and COPD, technological advancements, widespread smartphone usage, and a growing awareness …

Source: MENAFN - Indeterminate
Published on May 29, 2025

Krabbe Disease Market Poised For Growth During The Forecast Period (20252034) With Advancements In Gene Therapy And ...

(MENAFN- GlobeNewsWire - Nasdaq) The dynamics of the Krabbe disease market are expected to shift in the coming years due to the emergence of a new pipeline, increasing awareness of the disease, and rising healthcare spending worldwide. The drug candidates …

Source: MENAFN - Indeterminate
Published on May 28, 2025

Mitsubishi Tanabe Pharma America Announces U.S. FDA Acceptance of New Drug Application Resubmission for Investigational ...

JERSEY CITY, N.J., May 28, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) resubmission for investigational ND0612, a 24 …

Source: WISC Channel 3000 - Wisconsin - Neutral
Published on May 28, 2025

With new Alzheimer’s blood test cleared, a potential vaccine could be on the horizon

The journey to new Alzheimer’s disease drugs has been long, grueling and littered with pitfalls. Through failed trials and regulatory scrutiny, several new drugs promise concrete — albeit incremental — treatment for the devastating disease. Along the way, …

Source: PharmaVoice - Neutral
Published on May 28, 2025

Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programs The agreement includes proposed biosimilars to Ilaris® (canakinumab), Kesimpta® (ofatumumab) and an …

Distribution channels:
Published on Jun 1, 2025

Terrible News for Pfizer Stock Investors

The past three years have been challenging for Pfizer (PFE 0.11%). Revenue and earnings have moved in the wrong direction, as has the company's share price. The stock is down by 56% since 2022. Although Pfizer has made some efforts to turn things …

Source: myMotherLode - Pending
Published on May 31, 2025

Astellas Stays Competitive in Hot Gut Cancer Target, Paying $130M to License Evopoint Drug

Astellas Pharma already has the first FDA approval for a therapy that goes after Claudin 18.2, a protein whose overexpression on the surface of cells in gastrointestinal cancers makes it an attractive drug target. But the company has shown interest in …

Source: MedCity News - Neutral
Published on May 31, 2025

I have invested in dividends for 25 years—These stocks built my passive income factory from day one

Investing relif / Getty Images Key Points Seeking out financially reliable, consistent dividend payers has been a tremendous wealth-building strategy. Going forward, you can create a powerful dividend snowball effect by reinvesting all distributions. …

Source: 24/7 Wall St. - Pending

30 days 01:08:08

Featured Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 05:00 GMT

Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short ...

Press release – No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome Copenhagen, Denmark, June 2, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 05:00 GMT

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-...

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on June 2, 2025 - 05:00 GMT

Communiqué de presse : Sanofi acquiert Blueprint Medicines, enrichit son portefeuille dans les maladies immunologiques ...

Sanofi acquiert Blueprint Medicines, enrichit son portefeuille dans les maladies immunologiques rares et ajoute un pipeline d’immunologie de stade précoce Le portefeuille de Sanofi s’enrichit du seul médicament approuvé, en croissance rapide, pour la …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 1, 2025 - 23:30 GMT

Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

Tokyo, Japan and Cambridge, UK, 2 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Company (“ …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on June 2, 2025 - 08:00 GMT

Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development

MELBOURNE, Australia and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for food allergy, today announces the appointment of Louise …

Distribution channels: Companies, Technology ...
Published on June 2, 2025 - 08:08 GMT

Bracane Company Earns Ecovadis Silver Medal for Sustainability Excellence

Ranked Among Top 15% of Companies Globally, Underscoring Bracane’s Commitment to Environmental Stewardship, Social Responsibility, and Ethical Governance PLANO, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Bracane Company, Inc., a …

Distribution channels: Education, Energy Industry ...
Published on June 1, 2025 - 23:30 GMT

The Emerging Role of Sodium Lactate in Clean-Label Food Preservation and Its Ripple Effect on Industrial Demand Patterns

Sodium Lactate Market shifts from pharma to clean-label food, personal care, and eco-packaging, driven by demand for natural, multifunctional ingredients. NEWARK, DE, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: 𝐀 𝐐𝐮𝐢𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫 𝐢𝐧 𝐚 …

Distribution channels: Chemical Industry ...
Published on June 2, 2025 - 01:53 GMT

Senior-Friendly Packaging Market to Reach USD 8,747.657 Million by 2035, Driven by Aging Population | FMI

Japan’s aging population drives demand for senior-friendly packaging, with easy-open, ergonomic designs now common in food, pharma, and personal care. NEWARK, DE, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The senior friendly packaging …

Distribution channels: Business & Economy ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 818,201,453 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 08:08 GMT

Bracane Company Earns Ecovadis Silver Medal for Sustainability Excellence

Ranked Among Top 15% of Companies Globally, Underscoring Bracane’s Commitment to Environmental Stewardship, Social Responsibility, and Ethical Governance PLANO, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Bracane Company, Inc., a …

Distribution channels: Education, Energy Industry ...
Published on June 2, 2025 - 07:49 GMT

MOIN Launches Cross-Border Remittance Service via Toss App, Enhancing Accessibility for 28 Million Users

MOIN, a leading fintech company specializing in cross-border remittance solutions, has launched its cross-border money transfer service on Toss SEOUL, EUNPYEONG, SOUTH KOREA, June 2, 2025 /⁨EINPresswire.com⁩/ -- MOIN, a leading fintech company …

Distribution channels: Amusement, Gaming & Casino, Automotive Industry ...
Published on June 2, 2025 - 06:51 GMT

Narconon Arrowhead Hosts Celebration for Graduate's 25 Years of Sobriety

CANADIAN, OK, UNITED STATES, June 1, 2025 /⁨EINPresswire.com⁩/ -- The Narconon Arrowhead Drug and Alcohol Rehabilitation Program recently hosted a special celebration as Bobby Newman, a program graduate, marked 25 years of sobriety. Newman, who …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on June 1, 2025 - 23:16 GMT

Luis M. Gallardo Launches the Meta Pets Method, A Playful Path to Transformation for Therapists, Coaches, and Educators

A Card-Based System for Self-Inquiry, Healing, and Awakening in Education, Coaching, and Therapy. MIAMI, FL, UNITED STATES, June 1, 2025 /⁨EINPresswire.com⁩/ -- Author, hypnotherapist, and global well-being advocate Luis Miguel Gallardo announces …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 1, 2025 - 23:00 GMT

Impelsys Strengthens AI Transformation Strategy with AlgoShack Partnership

NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Impelsys, a global leader in technology solutions, is pleased to announce its strategic partnership with AlgoShack, a company that offers algoQA—a unified platform for end-to-end …

Distribution channels: Book Publishing Industry, Education ...
Published on June 2, 2025 - 05:00 GMT

Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short ...

Press release – No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome Copenhagen, Denmark, June 2, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 05:00 GMT

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options ...

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first and only FDA-approved interchangeable denosumab biosimilars available in US Improves access for patients …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 05:00 GMT

Communiqué de presse : Sanofi acquiert Blueprint Medicines, enrichit son portefeuille dans les maladies immunologiques ...

Sanofi acquiert Blueprint Medicines, enrichit son portefeuille dans les maladies immunologiques rares et ajoute un pipeline d’immunologie de stade précoce Le portefeuille de Sanofi s’enrichit du seul médicament approuvé, en croissance rapide, pour la …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 05:00 GMT

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-...

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 02:29 GMT

Colorado public health officials release additional locations for potential measles exposures

The DEN airport case has resulted in three additional confirmed cases of measles Denver (June 1, 2025) — The Colorado Department of Public Health and Environment and El Paso County Public Health have confirmed measles in two adult unvaccinated El Paso …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 2, 2025 - 02:06 GMT

Volunteers support the NHS for 6 million hours this year

Tens of thousands of people have volunteered to help the NHS over the last year, according to new figures. From people in their late teens to those in their late eights volunteers have helped with tasks such as directing loved ones around hospitals, …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 2, 2025 - 00:00 GMT

HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting

— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI Phase III China study — — Webcast to be held at 8:30 am HKT on Tuesday, June 3 to discuss the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 23:30 GMT

Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

Tokyo, Japan and Cambridge, UK, 2 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Company (“ …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 1, 2025 - 23:26 GMT

TORRAS Personal Cooling with Coolify Series: A Tech-Driven Solution for Comfort, Wellness, and Women's Health

LOS ANGELES, June 01, 2025 (GLOBE NEWSWIRE) -- As global temperatures continue to rise and daily comfort becomes a growing concern, TORRAS is making waves with its innovative Coolify series—a wearable air conditioner engineered to deliver rapid, personal …

Distribution channels:
Published on June 1, 2025 - 23:00 GMT

Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in ...

– New Drug Application based on positive results from the Phase 2 KOMET-001 trial – – FDA assigns a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2025 – – Potential first approval of a menin inhibitor for the treatment of adult …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 05:21 GMT

Smile Scarsdale Family Dental Celebrates One Year of Smiles as Trusted Family Dentist in Scarsdale

SCARSDALE, NY, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- Smile Scarsdale Family Dental is proud to celebrate its one-year anniversary of delivering exceptional family dental care to the Scarsdale community and surrounding areas. Since …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...
Published on June 1, 2025 - 17:12 GMT

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/...

Median DOR of 21.7 months with 80% of responders achieving a deep response (≥80% tumor shrinkage) Depth and durability translating to prolonged OS with median OS of 21.3 months and 2-year OS of 46% in HPV-negative HNSCC Conference call and webcast today at …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 14:45 GMT

Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated ...

Data Highlights Transformative Promise of CAR T in Solid Tumors Phase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients with CD70 TPS ≥ 50% Advanced or Metastatic RCC A Single Dose of ALLO-316 Achieved a 31% …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 14:00 GMT

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 ...

- RP1 plus nivolumab generated robust responses in both injected and non-injected lesions - - Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of response compared to superficial injections only and were …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on June 1, 2025 - 00:41 GMT

Planet TV Studios Presents New Frontiers Episode 'Highlighting Emerging Technologies' Featuring Athena Clinic & Dr. ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON,, FL, UNITED STATES, May 31, 2025 …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...